Spandan Medtech Private Limited
About Spandan Medtech Private Limited
Data last updated:
Spandan Medtech Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 15 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2020PTC374537. Its GSTIN is 07ABFCS0991K1ZY (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sanjive Kohli and Mehul Kohli.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 303th/F Block – A1 Aggarwal Complex Janakpuri, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.26 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹6.41 Lakh (net margin 5.1%) and EBITDA of ₹8.79 Lakh (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 187% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address303th/F Block – A1 Aggarwal Complex Janakpuri, Delhi, India – 110058
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Spandan Medtech Private Limited
The main business activity of Spandan Medtech is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Spandan Medtech Private Limited FY 2025 filings available
Spandan Medtech Private Limited reported revenue of ₹1.26 Cr (up 324% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Spandan Medtech Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 187% over three years, including 324% growth in the latest year. EBITDA rose 516% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Spandan Medtech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8.79 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.41 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Spandan Medtech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Spandan Medtech are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Spandan Medtech Private Limited
Spandan Medtech has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjive Kohli | Director | 15 Dec 2020 | 5 Years 10 Months | Current |
| Mehul Kohli | Director | 24 Aug 2024 | 2 Years 1 Months | Current |
| Manthan Kohli | Director | 15 Dec 2020 | 5 Years 10 Months | Current |
Peer Comparison of Spandan Medtech Private Limited
Spandan Medtech Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jai Guruji Bio Sciences Private Limited | ₹1.28 Cr (FY 2023) | •••• | •••• | 1.0% | •••• | Gurugram, Haryana, India |
| Rudra Brothers Private Limited | ₹1.27 Cr (FY 2024) | •••• | •••• | 112.0% | •••• | Delhi, India |
| Flexitech Medical Devices Private Limited | ₹1.27 Cr (FY 2024) | •••• | •••• | 256.0% | •••• | Jaipur, Rajasthan, India |
| Janrakshak Dispomed Devices Private Limited | ₹1.27 Cr (FY 2025) | •••• | •••• | 484.0% | •••• | Lucknow, Uttar Pradesh, India |
| White Cross Health Initiatives Private Limited | ₹1.27 Cr (FY 2023) | •••• | •••• | -82.0% | •••• | Bangalore, Karnataka, India |
| Spandan Medtech Private Limited this company | ₹1.26 Cr (FY 2025) | •••• | •••• | 324.0% | •••• | Delhi, India |
| Bassil Scientific Private Limited | ₹1.26 Cr (FY 2025) | •••• | •••• | 58.0% | •••• | Delhi, India |
| Niramaya Holistic Health Services Private Limited | ₹1.26 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Zon Bio Systems Private Limited | ₹1.26 Cr (FY 2023) | •••• | •••• | -18.0% | •••• | Delhi, India |
| Akshar the Speech and Hearing Clinic Private Limited | ₹1.26 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Lucknow, Uttar Pradesh, India |
| Paxit Earth Private Limited | ₹1.26 Cr (FY 2024) | •••• | •••• | •••• | Gmc, Assam, India |
Peers are the five companies nearest above and the five nearest below Spandan Medtech by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Spandan Medtech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Spandan Medtech Private Limited
Spandan Medtech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Spandan Medtech Private Limited
Spandan Medtech Private Limited has a workforce of 0 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Spandan Medtech Private Limited
Spandan Medtech Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Dharam Pal Kohli ceased to be Director on 26 Aug 2024.
Credit Ratings, Litigation & Regulatory Alerts for Spandan Medtech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Spandan Medtech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Spandan Medtech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Spandan Medtech Private Limited
Spandan Medtech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABFCS0991K1ZY | Delhi | Active | 13 Jan 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Spandan Medtech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spandan Medtech Private Limited
Spandan Medtech is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 15 December 2020 (6+ years old) and is registered under CIN U51909DL2020PTC374537.
Spandan Medtech reported revenue of ₹1.26 Cr for FY 2025 (up 324% YoY).
Spandan Medtech has 3 current directors:
- Sanjive Kohli - Director
- Mehul Kohli - Director
- Manthan Kohli - Director
Spandan Medtech reported a net profit of ₹6.41 Lakh (net margin 5.1%) and EBITDA of ₹8.79 Lakh (EBITDA margin 6.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Spandan Medtech is 187% over three years. In the latest year (FY 2025) revenue rose 324%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Spandan Medtech is 07ABFCS0991K1ZY, registered in Delhi.
The CIN (Corporate Identification Number) of Spandan Medtech is U51909DL2020PTC374537. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spandan Medtech was incorporated on 15 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Spandan Medtech by revenue are Jai Guruji Bio Sciences Private Limited, Rudra Brothers Private Limited, Flexitech Medical Devices Private Limited, Janrakshak Dispomed Devices Private Limited, White Cross Health Initiatives Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution).
Dharam Pal Kohli ceased to be Director on 26 Aug 2024. Mehul Kohli was appointed as Director on 24 Aug 2024. Manthan Kohli was appointed as Director on 15 Dec 2020. Spandan Medtech has 4 board changes on record in total.
The registered office of Spandan Medtech is at 303thF Block – A1 Aggarwal Complex Janakpuri, Delhi, India – 110058.